BioPhausia AB acquires Astrazeneca AB-Pharmaceutical from AstraZeneca PLC


SWEDEN - BioPhausia AB acquired the pharmaceutical portfolio of Astrazeneca AB, a Sodertalje-based manufacturer of pharmaceuticals, from AstraZeneca PLC, for ### mil Swedish kronor ($##.## mil US) in cash. The transaction was subject to regulatory and shareholders approvals and

Deal Information

Credit & Investment Research

Market Research

News